Scarica l'app Stockscreener
32.64
0.74%
0.24
Claritev Corp Borsa (CTEV) Ultime notizie
Claritev Corporation(NYSE: CTEV) added to Russell 2000 Value Benchmark - marketscreener.com
Claritev Corporation(NYSE: CTEV) added to Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Claritev Corporation – NYSE:CTEV - TradingView
Claritev Corporation(NYSE: CTEV) added to Russell 3000E Value Benchmark - marketscreener.com
Price to sales forward of Claritev Corporation – NYSE:CTEV - TradingView
Enterprise value to EBITDA forward of Claritev Corporation – NYSE:CTEV - TradingView
Enterprise value to revenue forward of Claritev Corporation – NYSE:CTEV - TradingView
Claritev Corp (CTEV) Institutional Confidence - TradingKey
Claritev (CTEV) Stock Faces Mixed Analyst Target Changes As Growth Execution Questions Build - Yahoo Finance
CTEV Forecast — Price Target — Prediction for 2027 - TradingView
Claritev Corporation Class A Actuals & Estimates (NYSE:CTEV) - TradingView
Claritev Can't Use 'Unclean Hands' Defense In Antitrust MDL - Law360
Claritev Says It Wasn't Target Of Criminal Antitrust Probe - Law360
Claritev Corporation Announces Participation in Truist Securities Healthcare Disruptors & Digital Health Conference - Business Wire
CCORF Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Claritev Corp (CTEV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Claritev Corp (CTEV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Claritev says US DOJ antitrust probe has been closed - MLex
Claritev Cleared of Criminal Probe, Faces Civil Inquiry - TipRanks
DOJ closes Claritev (NYSE: CTEV) antitrust grand jury as civil review continues - Stock Titan
Claritev Corp (CTEV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Claritev Corp (CTEV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Claritev Corp (CTEV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Claritev Corp (CTEV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Claritev Corp (CTEV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Claritev Corp (CTEV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
The No Surprises Act at a Crossroads: From Protection to Performance - marketscreener.com
Claritev Corporation (CTEV) Q1 2026 Earnings: EPS Misses Estimates, Revenue Unreported, Stock Declines - dars.gov.et
Is Claritev Corp (CTEV) a Bargain After 3.6% Drop? GF Value Says Undervalued - GuruFocus
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View - Yahoo Finance
Insider Buying: Nutter Carol Acquires Shares of Claritev Corp (C - GuruFocus
Claritev SVP Carol Nutter buys $24,856 in company stock By Investing.com - Investing.com Nigeria
Claritev SVP Carol Nutter buys $24,856 in company stock - Investing.com
Claritev (CTEV) chief people officer buys 875 company shares - Stock Titan
Claritev (CTEV) Q1 2026 Earnings Transcript - AOL.com
Piper Sandler Maintains Claritev(CTEV.US) With Buy Rating, Cuts Target Price to $61 - Moomoo
Claritev Cares and Elizabeth Dole Foundation Team Up to Help Military and Veteran Caregivers Navigate Mental Health Benefits - 01net
New free guides help military caregivers untangle mental health insurance - Stock Titan
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corp - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corporation (CTEV) And Encourages Shareholders to Connect - ACCESS Newswire
Arizona sues MultiPlan, major insurers, alleging a 'cartel' that underpaid doctors and hospitals - Arizona Mirror
Claritev Q1 2026 Earnings Call Transcript - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation | NYSE:CTEV | Press Release - Stockhouse
Claritev (CTEV) Receives Buy Rating and $32 Target from Canaccor - GuruFocus
CTEV Initiated Coverage by Canaccord Genuity -- Rating Set to Bu - GuruFocus
1.79%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):